Antiphospholipid syndrome nephropathy (APSN) in patients with lupus nephritis: A retrospective clinical and renal pathology study

Rheumatology International

Volumn 34, Issue 4, 2014, Pages 535-541

  Erre, Gian Luca ^a   Bosincu, Luisanna ^a   Faedda, Rossana ^a   Fenu, Patrizia ^a   Masala, Antonio ^a   Sanna, Marcella ^a   Taras, Loredana ^a   Longu, Maria Giovanna ^a   Piras, Marco ^a   Soro, Giovanni ^a   Satta, Andrea Ercole ^a   Passiu, Giuseppe ^a  

^a UNIVERSITY OF SASSARI   (Italy)

Author keywords

Antiphospholipid syndrome; Antiphospholipid syndrome nephropathy; Lupus nephritis; Systemic lupus erythematosus; Thrombotic microangiopathy

Indexed keywords

CARDIOLIPIN ANTIBODY; CREATININE; LUPUS ANTICOAGULANT; PHOSPHOLIPID ANTIBODY; BIOLOGICAL MARKER;

ADOLESCENT; ADULT; AGED; ANTIPHOSPHOLIPID SYNDROME; ANTIPHOSPHOLIPID SYNDROME NEPHROPATHY; ARTICLE; CLINICAL ARTICLE; CREATININE BLOOD LEVEL; DISEASE COURSE; DISEASE DURATION; END STAGE RENAL DISEASE; FEMALE; FIBROSING ALVEOLITIS; FOLLOW UP; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; HYPERTENSION; KIDNEY BIOPSY; KIDNEY DISEASE; LUPUS ERYTHEMATOSUS NEPHRITIS; MALE; MIDDLE AGED; PREVALENCE; PRIORITY JOURNAL; PROTEINURIA; RETROSPECTIVE STUDY; SYSTEMIC LUPUS ERYTHEMATOSUS; TREATMENT RESPONSE; YOUNG ADULT; BIOPSY; BLOOD; FIBROSIS; ITALY; KIDNEY; KIDNEY FAILURE, CHRONIC; LUPUS ERYTHEMATOSUS, SYSTEMIC; LUPUS NEPHRITIS; MULTIVARIATE ANALYSIS; PATHOLOGY; REMISSION; RISK; RISK FACTOR; SEVERITY OF ILLNESS INDEX; STATISTICAL MODEL; TIME; TREATMENT OUTCOME;

ADOLESCENT; ADULT; AGED; ANTIBODIES, ANTICARDIOLIPIN; ANTIPHOSPHOLIPID SYNDROME; BIOLOGICAL MARKERS; BIOPSY; CREATININE; DISEASE PROGRESSION; FEMALE; FIBROSIS; HUMANS; ITALY; KIDNEY; KIDNEY FAILURE, CHRONIC; LOGISTIC MODELS; LUPUS COAGULATION INHIBITOR; LUPUS ERYTHEMATOSUS, SYSTEMIC; LUPUS NEPHRITIS; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; ODDS RATIO; PREVALENCE; REMISSION INDUCTION; RETROSPECTIVE STUDIES; RISK FACTORS; SEVERITY OF ILLNESS INDEX; TIME FACTORS; TREATMENT OUTCOME; YOUNG ADULT;

EID: 84897051550     PISSN: 01728172     EISSN: 1437160X     Source Type: Journal    
DOI: 10.1007/s00296-013-2900-3     Document Type: Article

References (35)

1. Hughes G (1993) The antiphospholipid syndrome: 10 years on. Lancet 342:341-344
2. Asherson RA, Cervera R (2008) Microvascular and microangiopathic antiphospholipid-associated syndromes ("MAPS"): semantic or antisemantic? Autoimmun Rev 7:164-167
3. Kant KS, Pollak VE, Weiss MA, Glueck HI, Miller AN, Hess EV (1981) Glomerular thrombosis in systemic lupus erythematosus: prevalence and significance. Medicine (Baltimore) 60:71-86 (Pubitemid 11047409)
4. Glueck HI, Kant KS, Weiss MA, Pollak VE, Miller MA, Coots M (1985) Thrombosis in systemic lupus erythematosus. Relation to the presence of circulating anticoagulants. Arch Intern Med 145:1389-1395 (Pubitemid 15049790)
5. Bhandari S, Harnden P, Brownjohn AM, Turney JH (1998) Association of anticardiolipin antibodies with intraglomerular thrombi and renal dysfunction in lupus nephritis. Q J Med 91:401-409 (Pubitemid 28286839)
6. Kincaid-Smith P, Fairly KF, Kloss M (1998) Lupus anticoagulant associated with renal thrombotic microangiopathy and pregnancy-related renal failure. Q J Med 68:795-815
7. D'Agati V, Kunis C, Williams G, Appel GB (1990) Anticardiolipin antibody and renal disease: a report of three cases. J Am Soc Nephrol 1:777-784
8. Nochy D, Daugas E, Droz D et al (1999) The intrarenal vascular lesions associated with primary antiphospholipid syndrome. J Am Soc Nephrol 10:507-518 (Pubitemid 29117632)
9. Griffiths MH, Papadaki L, Neild GH (2000) The renal pathology of primary antiphospholipid syndrome: a distinctive form of endothelial injury. QJM 93:457-467 (Pubitemid 30459924)
10. Cervera R, Piette JC, Font J et al (2002) Antiphospholipid syndrome: clinical and immunologic manifestations and patterns of disease expression in a cohort of 1,000 patients. Arthr Rheum 46:1019-1027
11. Sinico RA, Cavazzana I, Nuzzo M et al (2010) Renal involvement in primary antiphospholipid syndrome: retrospective analysis of 160 patients. Clin J Am Soc Nephrol 5:1211-1217
12. Daugas E, Nochy D, Huong DLT et al (2002) Antiphospholipid syndrome nephropathy in systemic lupus erythematosus. J Am Soc Nephrol 13:42-52 (Pubitemid 34042010)
13. Tektonidou MG, Sotsiou F, Nakopoulou L, Vlachoyiannopoulos PG, Moutsopoulos HM (2004) Antiphospholipid syndrome nephropathy in patients with systemic lupus erythematosus and antiphospholipid antibodies: prevalence, clinical associations, and long-term outcome. Arthr Rheum 50:2569-2579
14. Cheunsuchon B, Rungkaew P, Chawanasuntorapoj R, Pattaragarn A, Parichatikanond P (2007) Prevalence and clinicopathologic findings of antiphospholipid syndrome nephropathy in Thai systemic lupus erythematosus patients who underwent renal biopsies. Nephrology (Carlton) 12:474-480
15. Miranda JM, Jara LJ, Calleja C, Saavedra MA, Bustamante RM, Angeles U (2009) Clinical significance of antiphospholipid syndrome nephropathy (APSN) in patients with systemic lupus erythematosus (SLE). Reumatol Clin 5:209-213
16. Silvariño R, Sant F, Espinosa G et al (2011) Nephropathy associated with antiphospholipid antibodies in patients with systemic lupus erythematosus. Lupus 20:721-729
17. Fakhouri F, Noel LH, Zuber J et al (2003) The expanding spectrum of renal diseases associated with antiphospholipid syndrome. Am J Kidney Dis 41:1205-1211 (Pubitemid 36637975)
18. Levy Y, George J, Ziporen L et al (1998) Massive proteinuria as a main manifestation of primary antiphospholipid syndrome. Pathobiology 66:49-52 (Pubitemid 28140604)
19. Dorel M, Daniel L, Liprandi A, Lerda D, Pellissier JF (2000) Idiopathic membranous glomerulonephritis associated with primary antiphospholipid syndrome. Nephron 86:366-367
20. Saracino A, Ramunni A, Pannarale G, Coratelli P (2005) Kidney disease associated with primary antiphospholipid syndrome: clinical signs and histopathological features in an case experience of five cases. Clin Nephrol 63:471-476 (Pubitemid 40872626)
21. Uthman I, Khamashta M (2006) Antiphospholipid syndrome and the kidneys. Semin Arthr Rheum 35:360-367 (Pubitemid 43841893)
22. Miranda JM, Garcia-Torres R, Jara LJ, Medina F, Cervera H, Fraga A (1994) Renal biopsy in systemic lupus erythematosus: significance of glomerular thrombosis. Analysis of 108 cases. Lupus 3:25-29 (Pubitemid 24105466)
23. Moss KE, Isenberg DA (2001) Comparison of renal disease severity and outcome in patients with primary antiphospholipid syndrome, antiphospholipid syndrome secondary to systemic lupus erythematosus (SLE) and SLE alone. Rheumatology (Oxford) 40:863-867
24. Tan EM, Cohen AS, Fries JF et al (1982) The 1982 revised criteria for the classification of systemic lupus erythematosus. Arthr Rheum 25:1271-1277
25. Miyakis S, Lockshin MD, Atsumi T et al (2006) International consensus statement on an update of the classification criteria for definite antiphospholipid syndrome (APS). J Thromb Haemost 4:295-306
26. Bombardier C, Gladman DD, Urowitz MB et al (1992) Derivation of the SLEDAI. A disease activity index for lupus patients. The committee on prognosis studies in SLE. Arthr Rheum 35:630-640
27. Churg J, Sobin LH (1982) Renal disease classification and atlas of glomerular disease. Igaku-Shoim, Tokyo, pp 127-149
28. Austin HA 3rd, Muenz LR, Joyce KM, Antonovych TT, Balow JE (1984) Diffuse proliferative lupus nephritis: identification of specific pathologic features affecting renal outcome. Kidney Int 25:689-695
29. Wahl DG, Guillemin F, De E Maistre F, Perret-Guillaume C, Lecompte T et al (1998) Meta-analysis of the risk of venous thrombosis in individuals with antiphospholipid antibodies without underlying autoimmune disease or previous thrombosis. Lupus 7:15-22 (Pubitemid 28052657)
30. Galli M, Finazzi G, Norbis F, Marchioli R, Barbui T (1999) The risk of thrombosis in patients with lupus anticoagulants is predicted by their specific coagulation profile. Thromb Haemost 81:695-700 (Pubitemid 29216552)
31. Galli M, Luciani D, Bertolini G et al (2003) Lupus anticoagulants are stronger risk factors for thrombosis than anticardiolipin antibodies in the antiphospholipid syndrome: a systematic review of the literature. Blood 101:1827-1832 (Pubitemid 36237580)
32. Cervera R, Tektonidou MG, Espinosa G et al (2011) Task force on catastrophic antiphospholipid syndrome (APS) and non-criteria APS manifestations (I): catastrophic APS, APS nephropathy and heart valve lesions. Lupus 20:165-173
33. Moroni G, Ventura D, Riva P et al (2004) Antiphospholipid antibodies are associated with an increased risk for chronic renal insufficiency in patients with lupus nephritis. Am J Kidney Dis 43:28-36 (Pubitemid 38049432)
34. Levy Y, Ziporen L, Gilburd B et al (1996) Membranous nephropathy in primary antiphospholipid syndrome: description of a case and induction of renal injury in SCID mice. Hum Antib Hybrid 7:91-96 (Pubitemid 27105442)
35. Barber C, Herzenberg A, Aghdassi E et al (2012) Evaluation of clinical outcomes and renal vascular pathology among patients with lupus. Clin J Am Soc Nephrol 7:757-764